Chappuy M, Meroueh F, Trojak B, et al. (2021) Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder. Patient Prefer Adherence 15:1259-1267. (IF : 2,72)

Rolland B, Trojak B, Nourredine M, et al. (2021) Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone. Drug and Alcohol Dependence 220:108492. (IF : 5,03)

Giustiniani J, Nicolier M, Mayer JT, Chabin T, Masse C, Galmes N, Pazart L, Trojak B, Bennabi D, Vandel P, Haffen E, Gabriel D (2020) Behavioral and Neural Arguments of Motivational Influence on Decision Making During Uncertainty. Frontiers in Neuroscience 14:583 (IF : 4,68)

Bulteau S, Guirette C, Brunelin J, Poulet E, Trojak B, Richieri R, Szekely D, Bennabi D, Yrondi A, Rotharmel M, Bougerol T, Dall'Igna G, Attal J, Benadhira R, Bouaziz N, Bubrovszky M, Calvet B, Dollfus S, Foucher J, Galvao F, Gay A, Haesebaert F, Haffen E, Jalenques I, Januel D, Jardri R, Millet B, Nathou C, Nauczyciel C, Plaze M, Rachid F, Vanelle JM, Sauvaget A (2019) Mood disorders: When should we use repetitive transcranial magnetic stimulation? Presse Medicale 48(6):625-646 (IF : 1,39)

Giustiniani J, Joucla C, Bennabi D, Nicolier M, Chabin T, Masse C, Trojak B, et al. (2019) Behavioral and Electrophysiological Arguments in Favor of a Relationship between Impulsivity, Risk-Taking, and Success on the Iowa Gambling Task. Brain Sciences 9(10):248 (IF : 3,33)

Denis F, Pelletier JF, Chauvet-Gelinier JC, Rude N, Trojak B (2018) Oral Health Is a Challenging Problem for Patients with Schizophrenia: A Narrative Review. Iranian Journal of Psychiatry and Behavioral Sciences 12(1);e8062

Pujol CN, Paasche C, Laprevote V, Trojak B, Vidailhet P, Bacon E, Lalanne L (2018) Cognitive effects of labeled addictolytic medications. Progress in Neuro-Psychopharmacology and Biological Psychiatry 81:306–32. (IF : 4,32)

Trojak B, Sauvaget A, Fecteau S, et al (2017) Outcome of Non-Invasive Brain Stimulation in Substance Use Disorders: A Review of Randomized Sham-Controlled Clinical Trials. The Journal of Neuropsychiatry and Clinical Neurosciences 29:105–18. (IF : 1.85)

Meille V, Verges B, Lalanne L, Trojak B, et al (2017) Effects of Transcranial Magnetic Stimulation on the Hypothalamic-Pituitary Axis in Depression: Results of a Pilot Study. The Journal of Neuropsychiatry and Clinical Neurosciences 29:70–3. (IF : 1.85)

Quartier A, Poquet H, Gilbert-Dussardier B, Rossi M, Casteleyn AS, des Portes V, Feger C, Nourisson E, Kuentz P, Redin C, Thevenon J, Mosca-Boidron AL, Callier P, Muller J, Lesca G, Huet F, Geoffroy V, El Chehadeh S, Jung M, Trojak B, Le Gras S, Lehalle D, Jost B, Maury S, Masurel A, Edery P, Thauvin-Robinet C, Gerard B, Mandel JL, Faivre L, Piton A (2017) Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome. European Journal of Human Genetics 25:423–31. (IF : 3.64)

Trojak B, Zullino D, Achab S (2017) Brain stimulation to treat Internet addiction: A commentary. Addictive Behaviors 64:363–4. (IF : 2.69)

Meille V, Vergès B, Lalanne L, Jonval L, Duvilllard L, Chauvet-Gelinier JC, Bonin B, Trojak B (2016) Effects of transcranial magnetic stimulation effects on the hypothalamic-pituitary axis in depression: Results from a pilot study. Journal of Neuropsychiatry and Clinical Neurosciences 29(1):70-73. (IF : 1.85)